Cargando…
Cellular uptake of modified mRNA occurs via caveolae-mediated endocytosis, yielding high protein expression in slow-dividing cells
Nucleic acids have clear clinical potential for gene therapy. Plasmid DNA (pDNA) was the first nucleic acid to be pursued as a therapeutic molecule. Recently, mRNA came into play as it offers improved safety and affordability. In this study, we investigated the uptake mechanisms and efficiencies of...
Autores principales: | Del Toro Runzer, Claudia, Anand, Shivesh, Mota, Carlos, Moroni, Lorenzo, Plank, Christian, van Griensven, Martijn, Balmayor, Elizabeth R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250585/ https://www.ncbi.nlm.nih.gov/pubmed/37305166 http://dx.doi.org/10.1016/j.omtn.2023.05.019 |
Ejemplares similares
-
Unveiling the intricacies of gene delivery: Caveolae-mediated endocytosis induces efficient mRNA delivery in slow-dividing cells
por: den Roover, Sabine, et al.
Publicado: (2023) -
Caveolae/raft-dependent endocytosis
por: Nabi, Ivan R., et al.
Publicado: (2003) -
Tyrosine phosphorylation-dependence of caveolae-mediated endocytosis
por: Sverdlov, Maria, et al.
Publicado: (2007) -
Introduction of Caveolae Structural Proteins into the Protozoan Toxoplasma Results in the Formation of Heterologous Caveolae but Not Caveolar Endocytosis
por: Lige, Bao, et al.
Publicado: (2012) -
Lysosomal Trafficking of TGFBIp via Caveolae-Mediated Endocytosis
por: Choi, Seung-il, et al.
Publicado: (2015)